XML 62 R46.htm IDEA: XBRL DOCUMENT v3.20.1
Note 10 - Net Loss Per Share - Anti-dilutive Securities (Details) - shares
shares in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Potentially dilutive common shares (in shares) 31,111 25,075
Unvested Stock [Member]    
Potentially dilutive common shares (in shares) [1] 1,160 490
Convertible Preferred Stocks [Member]    
Potentially dilutive common shares (in shares) 15,905 11,127
Common Stock Warrants [Member]    
Potentially dilutive common shares (in shares) 1,964 1,376
IPO Warrants [Member]    
Potentially dilutive common shares (in shares) [2] 12,082 12,082
[1] Does not include [$ ] million shares and 10.8 million shares for the three months ended March 31, 2020 and 2019, respectively, of unvested stock because the performance conditions had not yet been satisfied.
[2] The IPO Warrants were issued in connection with our initial public offering in 2015. The IPO Warrants are exercisable at a price of $11.50 per share and expire on July 24, 2022. The Company may redeem the IPO Warrants at a price of $0.01 per IPO Warrant upon 30 days' notice only if the last sale price of our common stock is at least $17.50 per share for any 20 trading days within a 30-trading day period. If the Company redeems the IPO Warrants in this manner, the Company will have the option to do so on a cashless basis with the issuance of an economically equivalent number of shares of Company common stock.